Alumis (ALMS) Change in Account Payables (2023 - 2025)
Alumis' (ALMS) quarterly Change in Account Payables came in at $5.6 million in Q4 2025, up 74.31% year-on-year from $3.2 million in Q4 2024, and up 153.24% on a QoQ basis from -$10.4 million in Q3 2025.
Alumis (ALMS) Change in Account Payables (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Change in Account Payables data on file, last reported at $5.6 million in Q4 2025.
- On a quarterly basis, Change in Account Payables rose 74.31% year-over-year to $5.6 million in Q4 2025; TTM through Dec 2025 was -$6.0 million, a 170.96% decrease from a year earlier, with the FY2025 full-year figure at -$6.0 million, down 170.96% from the prior year.
- Change in Account Payables for Q4 2025 stood at $5.6 million, up from -$10.4 million in the prior quarter.
- Over the last five years, Change in Account Payables for ALMS reached as high as $5.7 million in Q1 2024 and fell as low as -$10.4 million in Q3 2025.
- Historically, Change in Account Payables has averaged $116200.0 across 3 years, with a median of $1.5 million in 2023.
- Across the five-year window, Change in Account Payables jumped 196.87% in 2024 and plunged 322.71% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$3.3 million in 2023, then soared by 196.87% to $3.2 million in 2024, then surged by 74.31% to $5.6 million in 2025.
- Per Business Quant data, the three most recent Change in Account Payables figures were $5.6 million in Q4 2025, -$10.4 million in Q3 2025, and $989000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 5.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | -10.42 Mn |
| Sep 30, 2025 | -10.42 Mn |
| Jun 30, 2025 | 989,000.00 |
| Jun 30, 2025 | 989,000.00 |
| Mar 31, 2025 | -2.15 Mn |
| Mar 31, 2025 | -2.15 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | -3.29 Mn |
| Dec 31, 2023 | -3.29 Mn |
| Sep 30, 2023 | 1.98 Mn |
| Sep 30, 2023 | 1.98 Mn |